Evidence map›Paper›PMID 30719565›Full record

ReviewEuropean journal of clinical pharmacology2019

Impact of drugs on venous thromboembolism risk in surgical patients.

Alenka Premuš Marušič Kovačič, Martin Caprnda, Aleš Mrhar, Peter Kubatka, Igor Locatelli, Barbora Zolakova, Ludovit Gaspar, Robert Prosecky, Peter Kruzliak, Robert Staffa and 3 more

Open access · greenAbstract readReview
PubMed Publisher
In one paragraph

Review in European journal of clinical pharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 4 countries.

Alenka Premuš Marušič KovačičMurska Sobota General Hospital, Murska Sobota, Slovenia.
Martin Caprnda1st Department of Internal Medicine, Faculty of Medicine, University Hospital and Comenius University in Bratislava, Mickiewiczova 2247/13, 811 07, Bratislava, Slovakia.
Aleš MrharDepartment of Biopharmaceutics and Pharmacokinetics, Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia.
Peter KubatkaDepartment of Medical Biology, Jessenius Faculty of Medicine, Comenius University in Bratislava, Malá Hora 4, 036 01, Martin, Slovakia. peter.kubatka@jfmed.uniba.sk.
Igor LocatelliDepartment of Biopharmaceutics and Pharmacokinetics, Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia.
Barbora ZolakovaDepartment of Experimental Carcinogenesis, Division of Oncology, Biomedical Center Martin, Jessenius Faculty of Medicine, Comenius University in Bratislava, 036 01 Martin, Slovakia.
Ludovit Gaspar1st Department of Internal Medicine, Faculty of Medicine, University Hospital and Comenius University in Bratislava, Mickiewiczova 2247/13, 811 07, Bratislava, Slovakia. ludovit.gaspar@fmed.uniba.sk.
Robert ProseckyDepartment of Internal Medicine, Brothers of Mercy Hospital, Brno, Polni 3, 63900, Brno, Czech Republic.
Peter KruzliakDepartment of Internal Medicine, Brothers of Mercy Hospital, Brno, Polni 3, 63900, Brno, Czech Republic. kruzliakpeter@gmail.com.ORCID http://orcid.org/0000-0002-7069-3784
Robert Staffa2nd Department of Surgery, Faculty of Medicine, Masaryk University and St. Anne's University Hospital, Brno, Czech Republic.
Luis RodrigoFaculty of Medicine, University of Oviedo, Central University Hospital of Asturias (HUCA), Oviedo, Spain.
Jozef Radonak1st Department of Surgery, Faculty of Medicine, Pavol Jozef Safarik University and University Hospital, 041 66 Kosice, Slovak Republic.
Danijel PetrovičFaculty of Medicine, University of Ljubljana, Vrazov trg 2, SI-1104, Ljubljana, Slovenia. daniel.petrovic@mf.uni-lj.si.
University of Ljubljana · SIComenius University Bratislava · SKMasaryk University · CZUniversidad de Oviedo · ESUniversity Hospital Bratislava · SKUniversity of Pavol Jozef Šafárik · SK

Funding

Ministerstvo Zdravotnictv? Cesk? Republiky 17-29701A
6 · The paper itself

Abstract

purposeThis review focuses on the most common drugs administered to surgical patients during the perioperative period that affect the risk of venous thromboembolism (VTE).

resultsAmong analgesics, the risk of VTE is increased in patients treated with diclofenac, ibuprofen, and rofecoxib, but not naproxen, while metamizole can confer a protective effect. The relationship between sedatives and VTE has not been sufficiently studied. Tricyclic antidepressants, low-potency serotonin reuptake inhibitors, and antipsychotics have been associated with increased risk of VTE. The use of diuretics in the perioperative period is poorly researched; however, hyponatremia is considered a risk factor. Other factors that may influence the risk of VTE include bridging anticoagulation, allogeneic transfusion, and hemostatic management before surgery. Pharmacotherapy for HIV or cancer may also increase VTE risk.

conclusionIncreased monitoring for VTE is therefore advisable in surgical patients and those receiving antipsychotics, antidepressants, diuretics, or analgesics.

Indexed as

Perioperative CareAnalgesicsAntidepressive AgentsAntipsychotic AgentsContraceptives, Oral, HormonalDiureticsHormone Replacement TherapyHumansHypnotics and SedativesRisk FactorsVenous ThromboembolismAnalgesicsAntidepressive AgentsAntipsychotic AgentsContraceptives, Oral, HormonalDiureticsHypnotics and SedativesAnalgesicsAntidepressantsAntipsychoticsBridging anticoagulationDiureticsOral contraceptivesSurgeryThromboprophylaxisTransfusionVenous thromboembolism

Identifiers

PMID30719565
OpenAlexW2912544969

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.